MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis

por Mak, Celia S. L., Yung, Mingo M. H., Hui, Lynn M. N., Leung, Leanne L., Liang, Rui, Chen, Kangmei, Liu, Stephanie S., Qin, Yiming, Leung, Thomas H. Y., Lee, Kai-Fai, Chan, Karen K. L., Ngan, Hextan Y. S., Chan, David W.
Publicado 2017

Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells

por Chen, Rain R., Yung, Mingo M. H., Xuan, Yang, Zhan, Shijie, Leung, Leanne L., Liang, Rachel R., Leung, Thomas H. Y., Yang, Huijuan, Xu, Dakang, Sharma, Rakesh, Chan, Karen K. L., Ngu, Siew-Fei, Ngan, Hextan Y. S., Chan, David W.
Publicado 2019

Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis

por Mo, Yulan, Leung, Leanne L., Mak, Celia S. L., Wang, Xueyu, Chan, Wai-Sun, Hui, Lynn M. N., Tang, Hermit W. M., Siu, Michelle K. Y., Sharma, Rakesh, Xu, Dakang, Tsui, Stephen K. W., Ngan, Hextan Y. S., Yung, Mingo M. H., Chan, Karen K. L., Chan, David W.
Publicado 2023